Our research established that GPR37 interacts with ATP1A1 to promote its ubiquitinated degradation, which in turn inhibits AKT phosphorylation and then suppresses ESCC proliferation, migration, and DNA damage repair processes. Here, GPR37 is linked to esophageal squamous cell carcinoma.